excalibur
Diamond Member
- Mar 19, 2015
- 21,560
- 41,661
- 2,290
Giving doses out of all proportion seems destined to guarantee failure.
Suddenly, the FDA revoked its emergency use authorization for hydroxychloroquine (HCQ), hard on the heels of the Lancet’s retraction of a significant study on HCQ that turned out to be a complete fraud – the handiwork of science hucksters in lab coats. The fake study shook the medical world internationally and hoisted a red flag of caution over the “science” represented in prestigious journals like The Lancet and the New England Journal of Medicine going forward. All of which makes the FDA’s timing on withdrawing hydroxychloroquine highly conspicuous, based, as it was, on two more very suspect HCQ studies.
Lethal Overdose?
French doctor Didier Raoult, who has treated over 3,000 patients with HCQ – with a 99.25% success rate and a case fatality rate of .75%, all of whom were over age 74 – used 600 mg of hydroxychloroquine with his patients daily. But the dosing protocol for the Recovery Study recommended that 2.4 grams of hydroxychloroquine be administered in the first 24 hours to patients with COVID-19.
These levels – four times (4X) what Didier Raoult used – were set by the WHO. They were used in both the Recovery and the Solidarity trials. There are no medical conditions for which these doses would be prescribed. Canadian and Norwegian trials also administered 1.55 grams of HCQ in the first 24 hours to COVID-19 patients. At such alarming dosing levels, the Recovery trial’s mortality rates were 34 times higher than those in Didier Raoult’s study.
For context, it’s important to note that the recommended dosage for treating lupus or arthritis with HCQ is 200-400 mg, and for acute malaria, it is 600 mg. The amounts used in the Solidarity, Recovery, Norwegian, and Canadian trials constitute a potentially lethal dose, according to a 1979 study commissioned by the WHO. In that study, consultant, H. Weniger looked at 335 episodes of adult poisoning by chloroquine drugs. He determined that a single dose of 1.5-2.0 grams of hydroxychloroquine “may be fatal.”
Why did the WHO establish these massive doses of HCQ for trials around the world when they knew from their own study that it could be lethal?
...
Lethal Overdose?
French doctor Didier Raoult, who has treated over 3,000 patients with HCQ – with a 99.25% success rate and a case fatality rate of .75%, all of whom were over age 74 – used 600 mg of hydroxychloroquine with his patients daily. But the dosing protocol for the Recovery Study recommended that 2.4 grams of hydroxychloroquine be administered in the first 24 hours to patients with COVID-19.
These levels – four times (4X) what Didier Raoult used – were set by the WHO. They were used in both the Recovery and the Solidarity trials. There are no medical conditions for which these doses would be prescribed. Canadian and Norwegian trials also administered 1.55 grams of HCQ in the first 24 hours to COVID-19 patients. At such alarming dosing levels, the Recovery trial’s mortality rates were 34 times higher than those in Didier Raoult’s study.
For context, it’s important to note that the recommended dosage for treating lupus or arthritis with HCQ is 200-400 mg, and for acute malaria, it is 600 mg. The amounts used in the Solidarity, Recovery, Norwegian, and Canadian trials constitute a potentially lethal dose, according to a 1979 study commissioned by the WHO. In that study, consultant, H. Weniger looked at 335 episodes of adult poisoning by chloroquine drugs. He determined that a single dose of 1.5-2.0 grams of hydroxychloroquine “may be fatal.”
Why did the WHO establish these massive doses of HCQ for trials around the world when they knew from their own study that it could be lethal?
...
FDA Hydroxychloroquine Ban, Fake Science, and Political Agendas - Liberty Nation News
The FDA suddenly revoked its emergency use authorization for hydroxychloroquine, based on two very suspect HCQ studies - one of which has been retracted.
www.libertynation.com